Terms: = Prostate cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
540 results:
1. CD44 and CD133 protein expression might serve as a prognostic factor for early occurrence castration-resistant prostate cancer.
Dwina Y; Zaid LSM; Saraswati M; Rachmadi L; Kekalih A; Rahadiani N; Louisa M; Agustina H; Mochtar CA; Hamid ARAH
Prostate; 2024 Jun; 84(8):738-746. PubMed ID: 38528654
[TBL] [Abstract] [Full Text] [Related]
2. SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression.
Liao LX; Zhang M; Xu X; Zhang S; Guo YZ
Front Biosci (Landmark Ed); 2024 Feb; 29(2):69. PubMed ID: 38420826
[TBL] [Abstract] [Full Text] [Related]
3. Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applications.
Zhang X; Barnett E; Smith J; Wilkinson E; Subramaniam RM; Zarrabi A; Rodger EJ; Chatterjee A
Int Rev Cell Mol Biol; 2024; 383():41-66. PubMed ID: 38359970
[TBL] [Abstract] [Full Text] [Related]
4. Bone marrow metastasis in nonhematological malignancies: A study from tertiary care center.
Singh A; Rawat S; Kushwaha R; Jain M; Verma SP; Verma N; Singh US
Ann Afr Med; 2024; 23(1):91-99. PubMed ID: 38358178
[TBL] [Abstract] [Full Text] [Related]
5. Copy Number Gain in Androgen Receptors Predicts the Poor prognosis in Japanese Castration-resistant prostate cancer.
Sakamoto S; Ando K; Pae S; Zhao X; Sakai K; Sato K; Saito S; Yamada Y; Rii J; Goto Y; Sazuka T; Imamura Y; Anzai N; Akakura K; Nishio K; Ichikawa T
Anticancer Res; 2024 Feb; 44(2):639-647. PubMed ID: 38307556
[TBL] [Abstract] [Full Text] [Related]
6. prostate cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-Staging System.
Miyamoto H; Teramoto Y; Numbere N; Wang Y; Joseph JV
Mod Pathol; 2024 Mar; 37(3):100429. PubMed ID: 38266919
[TBL] [Abstract] [Full Text] [Related]
7. Occurrence and Risk Factors for Acute Urinary Retention and Urinary Tract Infection in Patients Undergoing Urinary Drainage after Colorectal Resection.
Song Z; Yu L; Wu Q; Zhang Y
Arch Esp Urol; 2023 Dec; 76(10):772-779. PubMed ID: 38186070
[TBL] [Abstract] [Full Text] [Related]
8. SIGNIFICANCE OF OSTEOPONTIN FOR PREDICTING AGGRESSIVENESS OF prostate cancer.
Lukianova N; Zadvornyi Т; Borikun Т; Mushii О; Pavlova А; Tymoshenko А; Stakhovskyi Е; Vitruk I; Сhekhun V
Exp Oncol; 2023 Dec; 45(3):312-321. PubMed ID: 38186024
[TBL] [Abstract] [Full Text] [Related]
9. Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25.
Yun H; Jeong HR; Kim DY; You JE; Lee JU; Kang DH; Koh DI; Ryu YS; Bae S; Jin DH
J Cell Mol Med; 2024 Feb; 28(3):e18104. PubMed ID: 38183356
[TBL] [Abstract] [Full Text] [Related]
10. Characteristics and survival of primary urothelial carcinoma of the prostate: A multi-center retrospective study of 18 cases.
Ji J; Liu T; Yao Y; Liu W; Ning H; Wang T; Zhang G
Neoplasia; 2024 Jan; 47():100961. PubMed ID: 38142529
[TBL] [Abstract] [Full Text] [Related]
11. Clinical impact of perineural invasion encircled completely vs. incompletely by prostate cancer on needle core biopsy.
Nwanze J; Teramoto Y; Wang Y; Miyamoto H
Hum Pathol; 2024 Jan; 143():71-74. PubMed ID: 38135063
[TBL] [Abstract] [Full Text] [Related]
12. Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway.
Li M; Bai G; Cen Y; Xie Q; Chen J; Chen J; Chen Q; Zhong W; Zhou X
J Transl Med; 2023 Dec; 21(1):884. PubMed ID: 38057852
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Outcomes of Small Cell Carcinoma of the Genitourinary Tract and the Prognostic Significance of the Tumor Immune Microenvironment.
Hyung J; Kim HD; Kim GH; Cho YM; Ryu YM; Kim SY; Park I; Yoon S; Lee JL
Cancer Res Treat; 2024 Apr; 56(2):624-633. PubMed ID: 38037320
[TBL] [Abstract] [Full Text] [Related]
14. Association between sociodemographic and clinical features, health behaviors, and health literacy of patients with prostate cancer and prostate cancer prognostic stage.
Braga R; Araújo N; Costa A; Lopes C; Silva I; Correia R; Carneiro F; Braga I; Pacheco-Figueiredo L; Oliveira J; Morais S; Tedim Cruz V; Pereira S; Lunet N
Eur J Cancer Prev; 2024 May; 33(3):243-251. PubMed ID: 37997910
[TBL] [Abstract] [Full Text] [Related]
15. miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response.
Hashemi M; Khosroshahi EM; Chegini MK; Abedi M; Matinahmadi A; Hosnarody YSD; Rezaei M; Saghari Y; Fattah E; Abdi S; Entezari M; Nabavi N; Rashidi M; Raesi R; Taheriazam A
Pathol Res Pract; 2023 Nov; 251():154906. PubMed ID: 37939448
[TBL] [Abstract] [Full Text] [Related]
16. Prevalence and prognosis of bone metastases in common solid cancers at initial diagnosis: a population-based study.
Zhang J; Cai D; Hong S
BMJ Open; 2023 Oct; 13(10):e069908. PubMed ID: 37865405
[TBL] [Abstract] [Full Text] [Related]
17. Primary signet ring cell carcinoma of prostate: A rare case report and review of literature.
Gupta M; Budhwar A; Prasad N; P Prasad SKS; Singh S
J Cancer Res Ther; 2023; 19(5):1075-1078. PubMed ID: 37787266
[TBL] [Abstract] [Full Text] [Related]
18. Overall Survival of Metastatic prostate cancer Patients According to Location of Visceral Metastatic Sites.
Tappero S; Piccinelli ML; Incesu RB; Cano Garcia C; Barletta F; Morra S; Scheipner L; Baudo A; Tian Z; Parodi S; Dell'Oglio P; de Cobelli O; Graefen M; Chun FKH; Briganti A; Longo N; Ahyai S; Carmignani L; Saad F; Shariat SF; Suardi N; Borghesi M; Terrone C; Karakiewicz PI
Clin Genitourin Cancer; 2024 Apr; 22(2):47-55.e2. PubMed ID: 37690970
[TBL] [Abstract] [Full Text] [Related]
19. Impact of Prior cancer on the prognosis of Patients with Chondrosarcoma: A Population-Based Study of the SEER Database.
Qian J; Dai S; Wang H
Altern Ther Health Med; 2023 Nov; 29(8):674-679. PubMed ID: 37678875
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of holmium laser, bipolar and conventional monopolar transurethral resection of bladder tumour in primary non-muscle invasive bladder cancer.
Elmekawy S; Taha DE; Nabeeh HE; Ibrahim A; Zeid AE; Abdelbaky T
J Pak Med Assoc; 2023 Apr; 73(Suppl 4)(4):S251-S256. PubMed ID: 37482868
[TBL] [Abstract] [Full Text] [Related]
[Next]
